AU2019252933B2 - Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof - Google Patents

Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof

Info

Publication number
AU2019252933B2
AU2019252933B2 AU2019252933A AU2019252933A AU2019252933B2 AU 2019252933 B2 AU2019252933 B2 AU 2019252933B2 AU 2019252933 A AU2019252933 A AU 2019252933A AU 2019252933 A AU2019252933 A AU 2019252933A AU 2019252933 B2 AU2019252933 B2 AU 2019252933B2
Authority
AU
Australia
Prior art keywords
salt
compound
structural formula
och3
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019252933A
Other languages
English (en)
Other versions
AU2019252933A1 (en
Inventor
Daniel Blair
Andrew Blake
Martin D. Burke
Alexander G. Cioffi
Anthony S. Grillo
Anna Santamaria
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois System
Original Assignee
University of Illinois at Urbana Champaign
University of Illinois System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois at Urbana Champaign, University of Illinois System filed Critical University of Illinois at Urbana Champaign
Publication of AU2019252933A1 publication Critical patent/AU2019252933A1/en
Priority to AU2025220735A priority Critical patent/AU2025220735A1/en
Application granted granted Critical
Publication of AU2019252933B2 publication Critical patent/AU2019252933B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/717—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a seven- to twelve-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/22—Unsaturated compounds having a carboxyl group bound to a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
AU2019252933A 2018-04-13 2019-04-12 Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof Active AU2019252933B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025220735A AU2025220735A1 (en) 2018-04-13 2025-08-20 Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862657127P 2018-04-13 2018-04-13
US62/657,127 2018-04-13
PCT/US2019/027314 WO2019200314A2 (en) 2018-04-13 2019-04-12 Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025220735A Division AU2025220735A1 (en) 2018-04-13 2025-08-20 Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
AU2019252933A1 AU2019252933A1 (en) 2020-11-26
AU2019252933B2 true AU2019252933B2 (en) 2025-09-04

Family

ID=68163807

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019252933A Active AU2019252933B2 (en) 2018-04-13 2019-04-12 Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof
AU2025220735A Pending AU2025220735A1 (en) 2018-04-13 2025-08-20 Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025220735A Pending AU2025220735A1 (en) 2018-04-13 2025-08-20 Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof

Country Status (8)

Country Link
US (1) US12084411B2 (https=)
EP (1) EP3773900A4 (https=)
JP (1) JP7503310B2 (https=)
KR (2) KR20260011772A (https=)
CN (1) CN112672786A (https=)
AU (2) AU2019252933B2 (https=)
CA (1) CA3095945A1 (https=)
WO (1) WO2019200314A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019252933B2 (en) 2018-04-13 2025-09-04 The Board Of Trustees Of The University Of Illinois Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof
EP4045025A4 (en) * 2019-10-16 2023-11-22 Kinesid Therapeutics, Inc. TROPOLONE DERIVATIVES AND THEIR TAUTOMERS FOR IRON REGULATION IN ANIMALS
US20230406803A1 (en) * 2019-10-16 2023-12-21 Kinesid Therapeutics, Inc Tropolone derivatives and tautomers thereof for iron regulation in animals
CN114436909B (zh) * 2022-01-26 2023-05-30 河南科技大学 一种磺酰基桧木醇类衍生物及其制备方法和应用
CN115093356B (zh) * 2022-06-21 2024-02-23 广东医科大学 一种铁死亡诱导剂的制备方法与应用
JP2025531628A (ja) * 2022-09-30 2025-09-22 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 神経変性疾患の処置方法
CN120282778A (zh) * 2022-09-30 2025-07-08 伊利诺伊大学评议会 氘化扁柏酚衍生物
CN117547525A (zh) * 2023-12-29 2024-02-13 中国科学院长春应用化学研究所 天然产物小分子桧木醇在制备治疗非酒精性脂肪性肝炎药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066784A (en) 1976-06-17 1978-01-03 Ayerst, Mckenna And Harrison Ltd. Tropone derivatives
US4183955A (en) 1976-06-17 1980-01-15 Ayerst. McKenna & Harrison Limited Troponyl-oxamic acid derivatives for treating allergic conditions
JP2552870B2 (ja) * 1986-08-21 1996-11-13 塩野義製薬株式会社 抗マイコプラズマ剤および抗マイコプラズマ活性を有する化合物
JP2622836B2 (ja) * 1987-02-04 1997-06-25 富士写真フイルム株式会社 メチン色素
JPH02237964A (ja) 1989-03-13 1990-09-20 Nippon Shokubai Kagaku Kogyo Co Ltd トロポロン誘導体
AU2001258829A1 (en) * 2000-05-25 2001-12-03 Nippon Shinyaku Co. Ltd. Tropolone derivatives and pharmaceutical compositions
CN1247511C (zh) * 2000-12-26 2006-03-29 财团法人乙卯研究所 环庚三烯酚酮衍生物
JP2004238291A (ja) * 2003-02-03 2004-08-26 Osaka Organic Chem Ind Ltd 白血病細胞増殖阻害剤
US20100152301A1 (en) 2005-12-01 2010-06-17 Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services Treatment of Viral Infections
JP2008158060A (ja) 2006-12-21 2008-07-10 Kyocera Mita Corp 電子写真感光体
JP5948139B2 (ja) * 2012-05-11 2016-07-06 ヒノキ新薬株式会社 サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤
JP2015526396A (ja) * 2012-06-22 2015-09-10 ユニバーシティ オブ コネチカット 置換トロポロン誘導体およびその使用方法
WO2016112381A1 (en) * 2015-01-09 2016-07-14 The Board Of Trustees Of The University Of Illinois Restoring physiology in iron-deficient organisms using small molecules
WO2017156194A1 (en) 2016-03-08 2017-09-14 The Regents Of The University Of California Compositions and methods for inhibiting influenza rna polymerase pa endonuclease
US10980754B2 (en) * 2016-04-19 2021-04-20 Saint Louis University Anti-fungal compounds
AU2019252933B2 (en) 2018-04-13 2025-09-04 The Board Of Trustees Of The University Of Illinois Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Banwell, M. G. & Onrust, R., "A Versatile New Strategy for the Synthesis of Tropolone", Tetrahedron Letters, 1985, Vol.26, No.37, pp 4543-4546 *
Haworth, R. D. et al, "Purpurogallin. I", Journal of the Chemical Society (1948), pp. 1045-1051 *
LI JIN ET AL: "Novel [alpha]-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis", PHARMACOLOGICAL RESEARCH, vol. 113, 2016, pages 438 - 448 *
Nozoe, T. et al, "Oxidation and reduction products of 4-acetyltropolone and its methyl ethers", Bulletin of the Chemical Society of Japan (1971), Vol. 44, No. 7, pp. 1951-1956 *
SOPHIA N. ONONYE ET AL: "Tropolones As Lead-Like Natural Products: The Development of Potent and Selective Histone Deacetylase Inhibitors", ACS MEDICINAL CHEMISTRY LETTERS, vol. 4, no. 8, 8 August 2013 (2013-08-08), pages 757 - 761 *

Also Published As

Publication number Publication date
JP2021521116A (ja) 2021-08-26
JP7503310B2 (ja) 2024-06-20
KR20210020876A (ko) 2021-02-24
EP3773900A2 (en) 2021-02-17
US20210163393A1 (en) 2021-06-03
CA3095945A1 (en) 2019-10-17
WO2019200314A2 (en) 2019-10-17
WO2019200314A3 (en) 2019-11-21
AU2025220735A1 (en) 2025-09-11
CN112672786A (zh) 2021-04-16
US12084411B2 (en) 2024-09-10
EP3773900A4 (en) 2022-03-30
KR102907811B1 (ko) 2026-01-02
AU2019252933A1 (en) 2020-11-26
KR20260011772A (ko) 2026-01-23

Similar Documents

Publication Publication Date Title
AU2019252933B2 (en) Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof
Del Balzo et al. Nonclinical characterization of the hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat, a novel treatment of anemia of chronic kidney disease
Grillo et al. Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals
Zeglis et al. Role of metalation in the topoisomerase IIα inhibition and antiproliferation activity of a series of α-heterocyclic-N4-substituted thiosemicarbazones and their Cu (II) complexes
EP3384908B1 (en) Modulating ferroptosis and treating excitotoxic disorders
CA2658793A1 (en) Quinoline derivatives
HUP0300838A2 (hu) Új heteroarilszármazékok, eljárás az előállításukra és gyógyszerként való alkalmazásuk
PT1301485E (pt) Derivados de acridina e sua utilização como agentes farmacêuticos
WO2008118790A1 (en) Dihydroindazole compounds useful in treating iron disorders
US20080207673A1 (en) Method for Treating Cancer, Coronary, Inflammatory and Macular Disease, Combining the Modulation of Zinc-and/or Copper Dependent Proteins
US10111893B2 (en) Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment
KR20190132622A (ko) 하이드록시벤조산 유도체, 및 그 제조방법 및 용도
EP2678339B1 (en) Methods and compositions for treating beta-thalassemia and sickle cell disease
ZA201002408B (en) Compounds for use in the treatment of colon cancer and method of manufacture
JP2015522025A (ja) コレステロール生合成阻害剤によるエストロゲン受容体βの誘発および癌の処置方法
Jhurry et al. Mossbauer study and modeling of iron import and trafficking in human jurkat cells
Shrivastav et al. Synthesis, characterization and antitumor studies of Mn (II), Fe (III), Co (II), Ni (II), Cu (II) and Zn (II) complexes of N-salicyloyl-N′-o-hydroxythiobenzhydrazide
CN101730565B (zh) 取代膦酸酯及其用于减少淀粉样聚集物的用途
CA3045365A1 (en) Compounds for treatment of senescence-related disorders
Yu et al. Rational design of copper ionophores for efficient induction of cuproptosis via simple n-alkyl modification
EP3976191B1 (en) Ruthenium (ii) complexes and their use as anticancer agents
EP3188726B1 (en) Pharmaceutical compounds
US20250325516A1 (en) Serotonin analogues for use in treating metalloptosis-associated disorders
WO2024245370A1 (zh) 一种组合产品、盐及其用途
WO2013061669A1 (ja) G2/m期停止及び細胞死を誘導するベンゾヒドラジド誘導体

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)